The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T, Maezawa Y, Hashimoto I, Hara K, Kazama K, Komori K, Kato A, Otani K, Tamagawa A, Cho H, Morita J, Kawahara S, Tanabe M, Oshima T, Saito A, Yukawa N, Rino Y.
Aoyama T, et al. Among authors: tamagawa a.
In Vivo. 2024 May-Jun;38(3):1253-1259. doi: 10.21873/invivo.13562.
In Vivo. 2024.
PMID: 38688590
Free PMC article.